Background
==========

Management of meningococcal disease requires immediate treatment of patients and chemoprophylaxis of contacts. For the latter, rifampicin is the most frequently used antibiotic. However, although it has been utilized routinely worldwide for more than 30 years, few cases of rifampicin resistant meningococci have been reported \[[@B1]\]. This scarce diffusion is intriguing and the reduced virulence of these strains in terms of the bacterium\'s survival in the bloodstream of mice, as shown in an *in vivo*model, suggests a major biological cost for the microorganism \[[@B2]\].

The resistance phenotype is correlated with a set of mutations in the *rpoB*gene, encoding the β subunit of RNA polymerase, resulting in amino acid substitutions at one of the following codons: Asp542, Ser548, His552, Ser557, Gly560 \[[@B3]-[@B6]\]. Moreover, other mechanisms have been described in both *Neisseria meningitidis*and in *Neisseria gonorrhoeae*\[[@B7],[@B8]\], i.e. resistance to diverse hydrophobic agents, including Triton X, is associated with mutations in the *mtrR*gene and in its promoter \[[@B7],[@B9],[@B10]\]. Overall, in other species, such as *Mycobacterium tuberculosis*, resistance was not related to any changes in the *rpoB*gene in around 5% of clinical rifampicin resistant isolates \[[@B11]\]. Rifampicin binds to DNA-dependent RNA polymerase and inhibits initiation of RNA synthesis which is not a mechanism of action shared with other antibiotics. This effect on RNA polymerase appears to result from drug binding in the polymerase subunit deep within the DNA/RNA channel where direct blocking of the elongating RNA can occur.

Little is known of the protein expression of *N. meningitidis*resistant to rifampicin and how this contributes to pathogenesis. In the present study, soluble proteins of two rifampicin resistant and one susceptible meningococci isolated in Italy, and previously described \[[@B5]\], were analysed by two-dimensional electrophoresis (2-DE) combined with mass spectrometry (MALDI-ToF). The method has been chosen because it is a comprehensive approach to investigate the protein content of a pathogen \[[@B12]\], and in this context helpful to identify differential expression in specific proteins in particular in rifampicin resistance meningococci.

Methods
=======

Bacterial strains and bacterial proteins extraction
---------------------------------------------------

Two rifampicin resistant (RIF^R^) 870 and 901 strains and one rifampicin susceptible (RIF^S^) 1958 serogroup C meningococci were analysed. The resistant strains showed two already described \[[@B5]\] mutations in the *rpoB*gene, the Asp542Val and the His552Tyr. Strain 870 had caused fatal septicaemia in a 34 year-old man and strain 901, meningitis in a 1 year-old infant. The RIF^S^1958 invasive strain was responsible for septicaemia in an infant aged 2, and since the absence of mutations in the *rpoB*gene, was chosen as control strain.

Bacterial protein extraction was performed according to the protocol previously described \[[@B13]\], with some modifications. In particular, the confluent bacterial growth was scraped from the plates and washed twice with PBS, suspended in 5 ml of lysis buffer (500 mM NaCl, 10 mM EDTA, 50 mM Tris pH 8.0) containing 0.3 mg/ml protease inhibitor (CompleteMini, Roche Diagnostic, Mannheim, Germany) and 150U DNase I (Roche Diagnostic).

The sample analysed by 2-DE approach corresponds to the cytosolic fraction, in which most of the proteins involved in the metabolic pathway and in essential biological processes have been described in bacteria.

Two-dimensional gel electrophoresis
-----------------------------------

Before electrophoresis an aliquot of protein extract corresponding to 350 μg of each sample was precipitated by adding nine volumes of cold-ethanol and keeping at -20°C overnight. Samples were centrifuged at 14. 000 *g*for 15 min at 4°C and pellets were dried and then dissolved in 185 μl of a rehydration buffer containing 7 M urea, 2 M thiourea, 2% w/v CHAPS, 50 mM DTT, 0.2% v/v Bio-Lytes™pH range 3-10. Each sample was loaded on an 11-cm precast Immobiline strip with a linear pH 4-7 gradient and three replica maps were performed. First- and second-dimension electrophoresis, and image analysis were carried out as already described by Mignogna *et al.*\[[@B13]\].

Protein identification
----------------------

Spots selected according to the procedure previously described \[[@B13]\], were manually excised from gels and digested with trypsin. Digestion was performed at 37°C overnight. Briefly, after several destaining steps using 50 mM ammonium bicarbonate (15 min), 50% acetonitrile in 50 mM ammonium bicarbonate (10 min) and 100% acetonitrile (15 min), subsequently, about 100 ng of trypsin (Trypsin Gold, Mass Spectrometry Grade, Promega, Madison, WI, USA), solubilised in 10 μl of a 25 mM ammonium bicarbonate digestion buffer, were added to vacuum-dried gel.

An aliquot (1 μl) of each mixture peptide was mixed with the same volume of α-cyano-4-hydroxy-trans-cinnamic acid matrix solution (5 mg/ml) in 70% acetonitrile containing 0.1% TFA (v/v) for MALDI-ToF analysis, performed in a Voyager-DE STR instrument (Applied Biosystems, Framingham, MA) equipped with a 337 nm nitrogen laser and operating in reflector mode. Mass data were obtained by accumulating several spectra from laser shots with an accelerating voltage of 20 kV. Two tryptic autolytic peptides were used for the internal calibration (*m/z*842.5100 and 2807.3145).

Identification by peptide mass fingerprint (PMF), was performed using the Mascot search engine version 2.2 \[[@B14]\] against NCBlnr database (10386837 sequences). Up to one missed cleavage, 50 ppm measurement tolerance, oxidation at methionine (variable modification) and carbamidomethyl cysteine (fixed modification) were considered. Post-translational modifications were not taken into account. Identifications were validated when the probability-based Mowse protein score was significant according to Mascot \[[@B15]\].

Statistical analysis of 2-DE maps
---------------------------------

For gel comparison, a statistical approach was applied when determining differentially expressed proteins using the PDQuest software (version 7.2.0, BioRad). Student\'s *t*-test was performed with 90% significance level to determine which proteins were differentially expressed between the susceptible and resistant strain. Thresholds for assigning differential expression between the two pools were set at a minimum 2-fold change for up-regulation and 0.5-fold for down-regulation. This fold change threshold was chosen to obtain significant changes in protein expression. To minimize variation due to experimental factors, the intensity of each spot was normalized on the basis of the total integrated optical density for the examined gel.

Sequence analysis of the genes encoding the four shifted proteins
-----------------------------------------------------------------

Chromosomal DNAs were extracted by using the QIAamp DNA mini kit (Qiagen, Hilden, Germany) according to the manufacturer\'s instruction. The encoding genes for the four shifted proteins of the meningococcal isolates were amplified by PCR and sequenced with primers designed on conservative regions of corresponding genes from *N. meningitidis*FAM18 (NCBI accession number AM421808) (Table [1](#T1){ref-type="table"}). All reactions were carried out with 100ng of purified chromosomal DNA, 5 μl of 10× reaction buffer, 0.01 mM of dNTP solution (Finnzymes, Finland), 2.5U HotStartTaq (Qiagen), 25pmol of each primer and sterile water to a final volume of 50 μl. Three different cycle conditions, changing for the annealing temperatures, were set up for the putative oxidoreductase, putative phosphate acyltransferase, putative zinc-binding alcohol dehydrogenase genes, respectively. In particular, 95°C for 15 minutes (hot-start); 30 cycles of 95°C for 30 seconds, 54°C -55°C-58°C for 30 seconds, and 72°C for 1 minute; and a final extension reaction at 72°C for 7 minutes.

###### 

Primers for amplification and sequence analyses of genes encoding the four shifted proteins found in rifampicin resistant meningococci

  Primer   Sequence (5\'→3\')                        Protein encoded (Locus tag)
  -------- ----------------------------------------- -------------------------------------------------------
  ADZ-f    ^576170^GCGTTTCAGACGGCATTTGT^576189^\*    putative zinc-binding alcohol dehydrogenase (NMC0547)
  ADZ-r    ^577320^GCCAGATTCAGACGGTATTCC^577300^\*   
  ICD-f    ^893762^ACGACGAATGTTCAGACGG^893780^\*     isocitrate dehydrogenase (NMC0897)
  ICD-r    ^896097^TGCCATAATAGCCACGCAC^896079^\*     
  PTA-f    ^607259^AAGCCGTTTGTCAGCCTT ^607276^\*     putative phosphate acyltransferase Pta (NMC0575)
  PTA-r    ^608401^CGGGCGTATTGGAAGGTTT ^608383^\*    
  POX-f    ^445746^AAAGCCGGATAAGTGGGAAC^445765^\*    putative oxidoreductase (NMC0426)

\* the position referring to the corresponding accession number of *N. meningitidis*strain FAM18, accession number AM421808.

Cycle conditions for the isocitrate dehydrogenase gene were set at 95°C for 15 minutes (hot-start); 30 cycles of 95°C for 30 seconds, 58°C for 30 seconds, and 72°C for 2 minutes; a final extension reaction at 72°C for 7 minutes.

The PCR products were analysed using the BLAST program <http://www.ncbi.nlm.nih.gov/BLAST/>; amino acid sequences were aligned using the ClustalW program <http://www.ebi.ac.uk/clustalw/>.

Analysis of *N. meningitidis*rifampicin resistant and susceptible strains growth curves
---------------------------------------------------------------------------------------

Meningococcal strains were incubated overnight on GC agar base (Oxoid, Basingstoke, UK) plates at 37°C with 5% CO~2.~Isolated colonies were inoculated in 4 ml GC broth plus rifampicin slightly stirring. The broth suspensions were immediately adjusted to an initial OD~600~of 0.08 and the growth was measured by reading optical density (OD) every 60 min.

The RIF^R^strains were grown on plates with 50 μg/ml of rifampicin. Each growth curve was repeated three times.

Results
=======

Analysis of protein expression by 2-DE
--------------------------------------

The 2-DE gels were performed in three replicates and variations in spot intensity were confirmed by statistical analysis. Representative 2-DE maps of the two RIF^R^870 and 901 strains and one RIF^S^1958, are reported in figure [1A](#F1){ref-type="fig"}. The number of detected spots was in a range of 320 to 450 for all replicates.

![**2-DE of proteins corresponding to cytosolic fractions from (A) rifampicin resistant 870 and 901 and rifampicin susceptible 1958 *N. meningitidis*strains; (B) close-up views of some protein spots differentially expressed; spot numbers correspond to those reported in the panel A**.](1471-2180-10-246-1){#F1}

As shown in figure [1A](#F1){ref-type="fig"}, there was a high similarity in protein pattern among the resistant and susceptible strains, with the majority of proteins ranging from pI 4 to 6 and with a molecular weight from 6000 to 195000 Da.

Protein identification by 2-DE gels and relative expression data were compared using PDQuest software; spots with a minimum of 2-fold change were chosen to define an up-expressed protein and 0.5-fold to define a down-expressed protein.

A total of twenty-three spots were found to be differentially expressed in both rifampicin resistant strains compared to the susceptible; all of them were subjected to the peptide mass fingerprinting (PMF) by MALDI-ToF analysis for protein identification. We performed the same analysis also on two isogenic rifampicin resistant meningococci mutants: the reference strain *N. meningitidis*serogroup B MC58 and one clinical isolate (data not shown).

Table [2](#T2){ref-type="table"} shows the functional classification of 23 up- and down-expressed proteins according to Universal Protein Knowledgebase (UniProtKB) database \[[@B16]\].

###### 

List of the 23 differentially expressed proteins found in rifampicin resistant *Neisseria meningitidis*strains

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Spot n   Protein name (gene) ^a^                                            Protein accession number   Ordered Locus Name^b^   Sequence coverage %   Mowse Score   MW~t~/pI~t~   Expression level ^c^   UniProtKB\
                                                                                                                                                                                                          Functional classification ^d^
  -------- ------------------------------------------------------------------ -------------------------- ----------------------- --------------------- ------------- ------------- ---------------------- -----------------------------------------------------------
  1        Aconitate hydratase (*acn*B)                                       A1KUZ6                     NMC1492                 51                    403           93412/5.38    up                     Carbohydrate metabolism: TCA cycle

  2        Piruvate dehydrogenase subunit E1 (*ace*E)                         A1KUG5                     NMC1278                 53                    426           99915/5.60    up                     Carbohydrate metabolism: pyruvate metabolism

  3        Putative phosphoenolpyruvate synthase (*pps*A)                     A1KSM6                     NMC0561                 26                    165           87128/6.01    up                     Carbohydrate metabolism: pyruvate metabolism

  4        Elongation factor G (*fus*A)                                       A1KRH0                     NMC0127                 30                    245           77338/5.08    up                     Genetic Information Processing: protein synthesis

  5        Isocitrate dehydrogenase (*icd*)                                   A1KTJ0                     NMC0897                 27                    229           80313/5.53    up\*                   Carbohydrate metabolism: TCA cycle

  6        60 kDa chaperonin (*gro*L)                                         A1KW52                     NMC1948                 41                    206           57535/4.90    down                   Genetic Information Processing: protein folding

  7        ATP synthase subunit α (*atp*A)                                    A1KW13                     NMC1908                 62                    281           55481/5.50    down                   Energy metabolism: oxidative phosphorilation

  8        N utilisation substance protein A (*nus*A)                         A1KV50                     NMC1556                 71                    426           55745/4.54    up                     Genetic Information Processing: protein synthesis

  9        Putative phosphate acyltransferase (NMC0575)                       A1KSN9                     NMC0575                 47                    263           57551/5.47    up\*                   Carbohydrate metabolism: propanoate metabolism

  10       Probable malate:quinone oxidoreductase (*mqo*)                     A1KWH2                     NMC2076                 36                    178           54091/5.58    down                   Carbohydrate metabolism: TCA cycle

  11       Trigger factor (*tig*)                                             A1KUE0                     NMC1250                 51                    209           48279/4.76    down                   Genetic Information Processing: protein folding

  12       Enolase (*eno*)                                                    A1KUB6                     NMC1220                 25                    129           46319/4.78    down                   Carbohydrate metabolism: glycolysis

  13       Cell division protein (*fts*A)                                     A1KVK9                     NMC1738                 40                    132           44348/5.33    down                   Genetic Information Processing: cell division

  14       Glutamate dehydrogenase (*gdh*A)                                   A1KVB4                     NMC1625                 54                    221           48731/5.80    up                     Energy metabolism: amino acid metabolism

  15       Putative zinc-binding alcohol dehydrogenase (NMC0547)              A1KSL2                     NMC0547                 38                    235           38283/5.32    down\*                 Carbohydrate metabolism: butanoate metabolism

  16       Succinyl-CoA ligase \[ADP-forming\] subunit beta (*suc*C)          A1KTM6                     NMC0935                 26                    125           41567/5.01    up                     Carbohydrate metabolism: TCA cycle

  17       DNA-directed RNA polymerase subunit α (*rpo*A)                     A1KRJ9                     NMC0158                 41                    184           36168/4.94    up                     Genetic Information Processing: transcription

  18       Carboxyphosphonoenol pyruvate phosphonomutase (*prp*B)             A1KVK6                     NMC1733                 73                    234           31876/5.22    down                   Carbohydrate metabolism: propanoate metabolism

  19       Putative malonyl Co-A acyl carrier protein transacylase (*fab*D)   A1KRY7                     NMC0305                 57                    158           31958/5.44    down                   Lipid metabolism: fatty acid biosynthesis

  20       Septum site-determining protein (*min*D)                           A1KRK2                     NMC0161                 29                    143           29768/5.70    down                   Genetic Information Processing: cell division

  21       Putative two-component system regulator (NMC0537)                  A1KSK4                     NMC0537                 74                    181           24821/5.44    down                   Environmental Information Processing: signal transduction

  22       Peptidyl-prolyl cis-trans isomerase (*ppi*B)                       A1KT50                     NMC0744                 84                    260           18840/5.04    down                   Genetic Information Processing: protein folding

  23       Putative oxidoreductase (NMC0426)                                  A1KSA1                     NMC0426                 52                    129           20759/5.74    down\*                 \-
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**^a^**According to the UniProtKB/TrEMBL entry <http://www.uniprot.org/>.

**^b^**Ordered Locus Name in *Neisseria meningitidis*serogroup C/serotype 2a (strain ATCC 700532/FAM18)

**^c^**Expression level of RIF ^R^*versus*RIF ^S^strains.

**^d^**Functional classification of the proteins according to KEGG: Kyoto Encyclopedia of Genes and Genomes <http://www.genome.jp/kegg/>.

\*Protein with changed pI in RIF ^R^versus RIF ^S^isolate.

Proteins belonging to the carbohydrate metabolism and the enzymes involved in the reactions of the tricarboxylic cycle (TCA) resulted up-expressed: in particular, the phosphenolpyruvate synthase \[A1KSM6\], the pyruvate dehydrogenase subunit E1 \[A1KUG5\], the glutamate dehydrogenase \[A1KVB4\], together with the isocitrate dehydrogenase \[A1KTJ0\], the succinyl-CoA synthetase subunit beta \[A1KTM6\] and the aconitate hydratase \[A9M175\]. Four proteins belonging to different metabolic pathways and those responsible for ATP production were down-expressed in both resistant strains: the malate quinone oxidoreductase \[A1KWH2\], the enolase \[A1KUB6\], the putative zinc-binding alcohol dehydrogenase \[A1KSL2\], the carboxyphosphonoenol pyruvate phosphonomutase \[A9M2G6\] and the F0F1 ATP synthase subunit α \[A9M121 (Table [2](#T2){ref-type="table"}).

A second group of proteins is involved in the regulation of the gene expression: the elongation factor G \[A1KRH0\], the transcription elongation factor NusA \[C9WY90\], and the DNA-directed RNA polymerase subunit α \[A1KRJ9\] were up-expressed. On the contrary, the DNA-binding response regulator \[A9M2D6\], involved in the transcription, the trigger factor \[A1KUE0\] involved in protein export, the 60 kDa chaperonin \[A1KW52\], that prevents misfolding and promotes the refolding of polypeptides, and the peptidyl-prolyl cis-trans isomerase \[A9M3M5**\]**, which accelerates the folding of proteins, were down-expressed.

The cell division protein \[A1KVK9\], the septum site-determining protein MinD \[A9M3T7\], the malonyl-CoA-acyl carrier protein transacylase \[A1KRY7\] and the putative oxidoreductase \[A9M1W2\], also resulted down-expressed.

Four of the 23 listed proteins in the Table2 had a different pI in both the resistant strains. The difference in the pI was well visualised in the 2-DE gels. As shown in figure [1B](#F1){ref-type="fig"}, the isocitrate dehydrogenase (spot 5) and the putative zinc-binding alcohol dehydrogenase (spot 15) were shifted to a more basic pI, while the putative phosphate acetyltransferase (spot 9) and the putative oxidoreductase (spot 23) were shifted to a more acidic pI.

Sequence analysis of the genes encoding the shifted proteins
------------------------------------------------------------

The four genes encoding proteins with a different pI were sequenced. In particular, NMC0426, NMC0547, NMC0575 and NMC0897 genes of the two resistant strains showed nucleotide mutations resulting in amino acid changes absent in the susceptible strain. All of them were considered missense mutations: 1) an arginine was replaced by a histidine residue at position 21 in the putative oxidoreductase; 2) an aspartic acid was replaced by a glycine residue at position 81 in the putative zinc-binding alcohol dehydrogenase; 3) an alanine was replaced by a serine residue at position 331 and an arginine by a leucine at position 351 in the putative phosphate acetyltransferase; 4) a threonine was replaced by an alanine residue at position 166; an isoleucine by a threonine at position 189; a glutamic acid by an alanine at position 212; an aspartic acid by a glycine at position 284; a valine by an alanine at position 710 and a valine by an alanine at position 731 in the isocitrate dehydrogenase.

Analysis of bacteria growth curves
----------------------------------

The rifampicin resistant strains grew normally and showed the same colony appearance as the rifampicin susceptible isolate, on GC agar plates with the naked eye or with a light microscope (data not shown). As shown in figure [2](#F2){ref-type="fig"}, after GC broth inoculation, there were differences in growth between the susceptible and resistant strains from the starting point of the inoculation (T0) to the stationary phase. In particular, the growth of the resistant strains showed primarily a delay in the onset of the logarithmic phase compared with the susceptible strain with different maximal OD~600~= 0.82 of 1958, OD~600~= 0.7 of 901, OD~600~= 0.65 of 870 (figure [2](#F2){ref-type="fig"}).

![**Growth curves in GC broth of rifampicin resistant and susceptible strains**. Error bars represent the standard deviation of three culture replicates.](1471-2180-10-246-2){#F2}

Discussion
==========

As a transformable bacterium *Neisseria meningitidis*is incline to acquire exogenous bacterial DNAs, but it has been relatively slow to acquire resistance. However, since it is a severe disease it is very important to monitor changes in the level of antibiotic susceptibility among clinical isolates. Resistance to rifampicin is only occasionally observed but the isolation of a resistant strain poses serious problems in managing the prophylaxis of close contacts. At present, it is unknown how changes in resistant phenotype correspond to different protein expression profiles.

Some studies reveal that the molecular mechanism of resistance is correlated to different amino acid changes in a short central region of the *rpo*B gene encoding the β-subunit of the RNA polymerase \[[@B3],[@B17]\]. Moreover, a scarce virulence of rifampicin resistant *N. meningitidis*isolates has been proved in an *in vivo*model \[[@B2]\].

It is interesting to focus on adaptation mechanisms under antibiotic challenge which have a cost in terms of fitness \[[@B18]\]. The results described in this paper permit to hypothesize that compensation for the rifampicin resistance phenotype may be responsible for the different protein expression in meningococcus. The phenomenon is not so rare among bacterial pathogens and the proteomic approach facilitates the comprehensive analysis of protein content. Most of the proteins recovered in the 2-DE maps belong to the cytosolic fraction. The latter permits to analyse differences in those proteins involved in metabolic pathways including the RNA polymerase, as the molecular target of rifampicin resistance. On the basis of the catalogue of proteins of the reference *N. meningitidis*strain MC58 \[[@B13]\], protein expression in two rifampicin resistant and one susceptible meningococci was analysed.

The proteomic approach allows us to define the differences in protein pathways compared to the protein set of rifampicin susceptible meningococci.

In our experimental conditions the soluble proteins obtained between pI 4 and 7 were identified in the different set of metabolic pathways. In particular, the results revealed a decrease of proteins, such as the 60 kDa chaperonin, trigger factor and peptidyl-prolyl cis-trans isomerase, involved in the accurate folding of polypeptides. Such results suggest that the bacteria may direct their metabolism towards the production of new polypeptide chains with a high energy cost.

Moreover, the proteins involved in crucial metabolic pathways showed an increased expression with particular regard to the catabolism of the pyruvate: the phosphoenolpyruvate synthase, involved in the conversion of pyruvate into phosphoenolpyruvate, and the pyruvate dehydrogenase subunit E1, that catalyzes the pyruvate decarboxylation into acetyl-CoA. Pyruvate is a key intersection in several metabolic pathways in bacteria \[[@B19]\], and so the altered expression of its catabolites may be reflected in the different pathways it generates. Three proteins, the putative phosphate acyltransferase, the carboxy phosphoenol pyruvate phosphomutase and the putative zinc-binding alcohol dehydrogenase, involved in the TCA cycle, gluconeogenesis and oxidation reaction, were differentially expressed. Similarly to the pyruvate, the acetyl-CoA too is an important molecule in the bacterial metabolism, since it is the starting point of many biochemical reactions \[[@B20]\]. Its main use is to convey the carbon atoms within the acetyl group to the TCA cycle to be oxidized for energy production. In this oxidative direction the two rifampicin resistant isolates showed an up-expression of the three main proteins of the TCA cycle: the aconitate hydratase, the isocitrate dehydrogenase and succinyl-CoA synthetase subunit beta. These results were in agreement with findings in a comparative study on resistant *Acinetobacter baumannii*\[[@B21]\].

The glutamate dehydrogenase, one of the essential enzymes for meningococcal pathogenesis in the infant rat model \[[@B22]\], was also up-regulated; this is of particular relevance since it belongs to the amino acid biosynthesis.

One of the advantages of the proteomic approach is that protein modifications that lead to changes in charge or size can directly be visualized \[[@B23]\]. In fact, four proteins in both resistant strains displayed a shift in their pI. The pI shifts were confirmed by the presence of amino acid changes due to missense mutations. In particular, the substitution of the cationic amino acid arginine with the neutral leucine was responsible for the acidic shift of putative phosphate acetyltransferase. On the other hand, the basic shift of putative zinc-binding alcohol dehydrogenase and isocitrate dehydrogenase was due to mutations of aspartic acid and glutamic acid to neutral ones. It is noteworthy that the two rifampicin resistant strains showed a different growth curve with a longer lag phase compared to the susceptible isolate. The analysis revealed that most differences in protein expression patterns were genetically encoded rather than induced by antibiotic exposure. Over-expression of stress proteins was expected, as they represent a common non-specific response by bacteria when stimulated by different shock conditions. Positive transcription regulators were found to be over-expressed in rifampicin resistance, suggesting that bacteria could activate compensatory mechanisms to assist the transcription process in the presence of RNA polymerase inhibitors. Other differences in expression profiles were related to proteins involved in central metabolism; these modifications suggest metabolic disadvantages of resistant mutants compared to sensitive ones. Of particular interest are the proteins involved in the cell division site. The altered proteins can affect the integrity of the Z ring at various stages. In the same way, it was hypothesized that the Z ring assembly could be both coordinated with the cell cycle and rendered responsive to cellular and environmental stresses.

The analysis of the protein differentially expressed may suggest the intricate series of events occurring in these strains. In this light, the growth results may be partially explained by a decrease expression of proteins such as the cell division protein and the septum site-determining protein MinD.

Conclusions
===========

Our findings reveal that we need a deeper understanding of the interplay between antibiotic resistance, biological fitness and virulence. Although our results are not sufficient to establish an unequivocal association between the differential protein expression and the resistant phenotype, they may be considered a starting point in understanding the decreased invasion capacity of

*N. meningitidis*rifampicin resistant strains. In fact, they support the hypothesis that the presence of more than one protein differentially expressed, having a role in the metabolism, influences the ability to infect and to spread in the population. Different reports have described and discussed how a drug resistant pathogen shows a high biological cost for survival \[[@B24],[@B25]\] and that may also explain why, for some pathogens, the rate of resistant organisms is relatively low considering the widespread use of a particular drug. This seems the case of rifampicin resistant meningococci.

Only the combination gained from different experimental methods and clinical data reporting will enable to model the adaptation response of such strains in their physiological network. Our aim was to improve knowledge of the microbial physiology of resistant meningococci and understand why, despite widespread use of rifampicin in prophylactic treatment, the resistant isolates continue to be so rare.
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